MA53787A - COMPOSITIONS FOR REDUCING SERUM URIC ACID - Google Patents

COMPOSITIONS FOR REDUCING SERUM URIC ACID

Info

Publication number
MA53787A
MA53787A MA053787A MA53787A MA53787A MA 53787 A MA53787 A MA 53787A MA 053787 A MA053787 A MA 053787A MA 53787 A MA53787 A MA 53787A MA 53787 A MA53787 A MA 53787A
Authority
MA
Morocco
Prior art keywords
compositions
uric acid
serum uric
reducing serum
reducing
Prior art date
Application number
MA053787A
Other languages
French (fr)
Inventor
Johan Hoegstedt
Eva Johnsson
James Mackay
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to MA053787A priority Critical patent/MA53787A/en
Publication of MA53787A publication Critical patent/MA53787A/en

Links

MA053787A 2018-10-01 2018-10-01 COMPOSITIONS FOR REDUCING SERUM URIC ACID MA53787A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA053787A MA53787A (en) 2018-10-01 2018-10-01 COMPOSITIONS FOR REDUCING SERUM URIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA053787A MA53787A (en) 2018-10-01 2018-10-01 COMPOSITIONS FOR REDUCING SERUM URIC ACID

Publications (1)

Publication Number Publication Date
MA53787A true MA53787A (en) 2022-01-05

Family

ID=82258006

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053787A MA53787A (en) 2018-10-01 2018-10-01 COMPOSITIONS FOR REDUCING SERUM URIC ACID

Country Status (1)

Country Link
MA (1) MA53787A (en)

Similar Documents

Publication Publication Date Title
MA46643A (en) METHODS AND COMPOSITIONS FOR RNA MAPPING
MA55037A (en) RNA POLYMERASE VARIANTS FOR CO-TRANSCRIPTIONAL STYLING
MA52486A (en) PYRIDAZINONES USED AS PARP7 INHIBITORS
MA55629A (en) ANTIBODY COMPOSITIONS FOR THE TREATMENT OF TUMORS
MA49279A (en) ANTIBODY COMPOSITIONS OPTIMIZED FOR THE TREATMENT OF EYE DISORDERS
MA47179A (en) COMPOSITION OF MANNURONIC DICARBOXYLIC ACID
IL281740A (en) Compositions for reducing serum uric acid
MA49628A (en) PROCESS FOR THE PURIFICATION OF HYALURONIC ACID
MA52154A (en) PHARMACEUTICAL COMPOSITION FOR ANEMIA
MA45611A (en) SPECIFIC TRICHOMA PROMOTERS FOR THE HANDLING OF CANNABINOIDS AND OTHER COMPOUNDS IN GLANDULAR TRICHOMA
MA52877A (en) STABILIZED HYALURONIC ACID
MA42614A (en) 5- (N-BENZYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL-ACETIC ACID DERIVATIVES USED AS HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS
MA45999A (en) ANTI-PD-1 ANTIBODIES, OR THEIR FRAGMENTS, FOR THE TREATMENT OF HEPATITIS B
MA54522A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
MA52545A (en) ANTIBODIES FOR CHELATED RADIONUCLEIDES
FR3047674B1 (en) USE OF ALKOXYLATED AMINES AS COLLECTING AGENTS FOR THE ENRICHMENT OF ORE
MA52801A (en) OLIGOMERIC CONJUGATES TO EXON SKIP FOR MUSCLE DYSTROPHY
FR3015290B1 (en) HYALURONIC ACID COMPOSITIONS COMPRISING MEPIVACAINE
FR3022462B1 (en) ORAL COMPOSITION OF ANTI-TNFALPHA ANTIBODY
FR3047675B1 (en) USE OF ALKOXYLATED AMINES AS COLLECTING AGENTS FOR THE ENRICHMENT OF ORE
MA55371A (en) ALTERNATIVE DETERGENTS FOR VIRAL INACTIVATION
MA45973A (en) BTK INHIBITOR COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
MA49704A (en) ISOTOPIC-LABELED BILIARY ACID DERIVATIVES
FR3035403B1 (en) USE OF ALKANE SULFONIC ACID FOR CLEANING IN SUGAR INDUSTRIES
MA41629A (en) COMPOSITIONS AND METHODS OF USE OF ANTI-MÜLLERIAN HORMONE FOR THE TREATMENT OF INFERTILITY